Literature DB >> 7014692

Characterization of synthetic medium antigens of Micropolyspora faeni and Thermoactinomyces candidus.

M W Treuhaft, R C Roberts, C Hackbarth, J J Marx.   

Abstract

A synthetic (Syn) medium was developed for growth of Micropolyspora faeni and Thermoactinomyces candidus, and optimum conditions for culture filtrate antigen production were found to be 3 days for T. candidus and 9 to 12 days for M. faeni. Appearance of proteolytic activity in the culture fluid supernatant coincided with a decrease in precipitating antigen content, protein content, and number of proteins on polyacrylamide gel electrophoresis (PAGE), probably as a result of proteolysis. The results suggest that protein content, number protein bands on PAGE, and proteolytic activity are predictive of precipitating antigen content. Antigens prepared in Syn medium were compared to those produced by the double-dialysis procedure and found to contain adequate amounts of antigenic material of sufficient quality to warrant clinical studies of their usefulness in the diagnosis of hypersensitivity pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014692     DOI: 10.1016/0091-6749(81)90083-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

1.  Health complaints and immunological markers of exposure to bioaerosols among biowaste collectors and compost workers.

Authors:  J Bünger; M Antlauf-Lammers; T G Schulz; G A Westphal; M M Müller; P Ruhnau; E Hallier
Journal:  Occup Environ Med       Date:  2000-07       Impact factor: 4.402

2.  Circulating IgG antibodies against fungal and actinomycete antigens in the sera of farmer's lung patients from different countries.

Authors:  V P Kurup; R A Mäntyjärvi; E O Terho; T H Ojanen; J H Kalbfleisch
Journal:  Mycopathologia       Date:  1987-05       Impact factor: 2.574

3.  Dot-immunobinding assay in the detection of IgG antibodies against farmer's lung antigens.

Authors:  R M Mäntyjärvi; V P Kurup
Journal:  Mycopathologia       Date:  1988-07       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.